According to CRISPR Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.22 B. In 2022 the company made an earning of -$0.66 B a decrease over its 2021 earnings that were of $0.37 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.16 B | -76.83% |
2022 | -$0.66 B | -271.4% |
2021 | $0.37 B | -209.04% |
2020 | -$0.35 B | -617.12% |
2019 | $67.3 M | -140.93% |
2018 | -$0.17 B | 146.86% |
2017 | -$66.61 M | 193.19% |
2016 | -$22.72 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -46.90% | ๐บ๐ธ USA |